An Australian stem cell and regenerative medicine company
April 23, 2021
Cynata’s Cymerus™ MSCs featured in Channel 9 news article on the SCUlpTOR Phase 3 Clinical Trial in Osteoarthritis
Channel 9 Health Reporter Gabriella Rogers explores the potential therapeutic benefits of Cynata’s MSC product in this serious disease and reviews the SCULpTOR trial with Professor David Hunter